Comparatyive determination of proteins, nitrogen-containing compounds and lipids content in blood plasma and ascitic fluid in patients with liver cirrhosis

Authors

DOI:

https://doi.org/10.15587/2519-4798.2017.109164

Keywords:

liver cirrhosis, ascitic fluid, blood plasma, pathogenetically substantiated treatment

Abstract

The aim of the work is the determination of proteins concentration in blood plasma and ascetic fluid and also toxic and atherogenic properties of ascitic fluid in patients with different stages of liver cirrhosis for the further choice of the individual treating tactics.

Research methods: 262 patients with liver cirrhosis, according to the diagnostic examination, who demonstrated the different severity of the pathological process in the liver parenchyma, were divided in 4 groups. In blood plasma and ascitic fluid of patients with liver cirrhosis were determined the concentration of protein, general content of bilirubin, concentration of final nitrogen, creatinine, urea, cholesterol and lecithin. 

Results: the obtained results demonstrate the disorder of the protein homeostasis and increase of the content of atherogenic lipoproteins, as a result of which hepatocyte membrane structures in patients with liver cirrhosis are destructed.  The content of studied components in ascitic fluid was identical (and sometimes even more) to the one in blood plasma – it allows to consider ascitic fluid as a plasma-replacing component in patients with liver cirrhosis, especially at the hepatic failure progression.

The degree of the disorder of the functional activity of the liver parenchyma was studied. The author of the article concludes that at choosing the surgical tactics in patients with liver cirrhosis, complicated with acsites, the degree of homeostasis disorders expressiveness must be taken into account

Author Biography

Alexander Dzygal, Odessa National Medical University Valikhovsky lane, 2, Odessa, Ukraine, 65082

PhD, Associate Professor

Department of Surgery Nо. 3 with the course of neurosurgery

References

  1. Harris, R., Harman, D. J., Card, T. R., Aithal, G. P., Guha, I. N. (2017). Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. The Lancet Gastroenterology & Hepatology, 2 (4), 288–297. doi: 10.1016/s2468-1253(16)30205-9
  2. Garbuzenko, D. V. (2016). Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding. Current Medical Research and Opinion, 32 (3), 467–475. doi: 10.1185/03007995.2015.1124846
  3. Andreev, G. N., Borisov, A. E., Ibadil'din, A. S. et. al. (1999). Patogenez, diagnostika i lechenie cirrozov pecheni, oslozhnennyh rezistentnym ascitom. Nizhniy Novgorod: Izd-vo Nizhegorod. gos. akad., 191.
  4. Ascione, T., Di Flumeri, G., Boccia, G., De Caro, F. (2017). Infections in patients affected by liver cirrhosis: an update. Infez Med., 25 (2), 91–97.
  5. Abdukadyrova, M. A. (1996). Virus gepatita S – odin iz glavnyh ekologicheskih faktorov hronicheskih gepatitov. Hronicheskie zabolevaniya pecheni ot virusnogo gepatita do cirroza pecheni. Tashkent, 4–5.
  6. Ibadil'din, A. S., Andreev, G. N., Borisov, A. E. (1999). Polisindromnost' cirroza pecheni. Nizhniy Novgorod: Izd-vo Nizhegorod. gos. akad., 196.
  7. Frolov, V. M., Petrunya, A. M., Pinskiy, L. L. (1996). Sostoyanie mikrogemodinamiki i immunnyy status u bol'nyh s hronicheskimi virusnymi porazheniyami pecheni i ih korrekciya. Vrachebnoe delo, 10-12, 144–146.
  8. Chesnokov, E. V., Kashuba, E. A. (2000). Hronicheskie gepatity i cirrozy pecheni virusnoy etiologii. Tyumen', 286.
  9. Reddy, S. S., Civan, J. M. (2016). From Child-Pugh to Model for End-Stage Liver Disease. Medical Clinics of North America, 100 (3), 449–464. doi: 10.1016/j.mcna.2015.12.002
  10. Ivashkin, V. T. (Ed.) (2008). Klinicheskie rekomendacii. Gastroenterologiya. Moscow: GEOTAR-Media, 208.
  11. Kerefova, Z. Sh., Pshegusova, M. H., Gubzhokova, O. Z. (2015). Mediko-social'nye aspekty cirrozov pecheni virusnoy etiologii. Simvol nauki, 11, 187–190.
  12. Yu, X., Guo, R., Ming, D., Su, M., Lin, C., Deng, Y. et. al. (2014). Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis. Journal of Gastroenterology and Hepatology, 29 (5), 1065–1072. doi: 10.1111/jgh.12459
  13. Alekseeva, I. N., Bryzgina, T. M., Pavlovich, S. I., Il'chevich, A. B. (1991). Pechen' i immunologicheskaya reaktivnost'. Kyiv, 150.
  14. Luk'yanov, S. V. (2005). Reinfuziya asciticheskoy zhidkosti pri hirurgicheskom lechenii sindroma portal'noy gipertenzii. Rostov: Rostovskiy gosudarstvennyy medicinskiy universitet, 20.
  15. Sapronova, N. G., Luk'yanov, S. V., Chigaeva, E. V. (2013). Osobennosti lecheniya pacientov s virus-associirovannym cirrozom pecheni. Sovremennye problemy nauki i obrazovaniya, 6. Available at: http://www.science-education.ru/ru/article/view?id=10856
  16. Yarema, I. V., Omarov, I. M. (2000). Hirurgicheskaya korrekciya gemo- i limfoobrashcheniya pri cirroze pecheni. Vestnik hirurgii, 159 (6), 12–14.
  17. Ginès, P., Cárdenas, A., Arroyo, V., Rodés, J. (2004). Management of Cirrhosis and Ascites. New England Journal of Medicine, 350 (16), 1646–1654. doi: 10.1056/nejmra035021
  18. Rochling, F. A., Zetterman, R. K. (2009). Management of Ascites. Drugs, 69 (13), 1739–1760. doi: 10.2165/11316390-000000000-00000
  19. Cadman, E., Bostwick, J. R., Eichberg, J. (1979). Determination of protein by a modified Lowry procedure in the presence of some commonly used detergents. Analytical Biochemistry, 96 (1), 21–23. doi: 10.1016/0003-2697(79)90548-7
  20. Noma, A., Okabe, H., Netsu-Nakayama, K., Ueno, Y., Shinohara, H. (1979). Improved method for simultaneous determination of cholesterol in high- and low-density lipoproteins. Clin. Chem., 25 (8), 1480–1481.
  21. Kucherenko, N. E., Vasil'ev, A. N. (1985). Lipidy. Kyiv: Vishcha shkola, 247.
  22. Scheiner, B., Lindner, G., Reiberger, T., Schneeweiss, B., Trauner, M., Zauner, C., Funk, G.-C. (2017). Acid-base disorders in liver disease. Journal of Hepatology. doi: 10.1016/j.jhep.2017.06.023
  23. Mogilevec, E. V. (2014). Hirurgicheskie aspekty korrekcii asciticheskogo sindroma u pacientov s cirrozom pecheni i portal'noy gipertenziey. Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta, 3, 5–11.
  24. Carrier, P., Jacques, J., Debette-Gratien, M., Legros, R., Sarabi, M., Vidal, E. et. al. (2014). L’ascite non liée à la cirrhose : physiopathologie, diagnostic et étiologies. La Revue de Médecine Interne, 35 (6), 365–371. doi: 10.1016/j.revmed.2013.12.001

Downloads

Published

2017-08-31

How to Cite

Dzygal, A. (2017). Comparatyive determination of proteins, nitrogen-containing compounds and lipids content in blood plasma and ascitic fluid in patients with liver cirrhosis. ScienceRise: Medical Science, (8 (16), 15–19. https://doi.org/10.15587/2519-4798.2017.109164

Issue

No. 8 (16) (2017)

Section

Medical Science

License

Copyright (c) 2017 Alexander Dzygal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.